Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Metabolic dysfunction-associated steatotic liver disease and cardiovascular pathology

Raising awareness of MASLD among the general public and at-risk populations, unifying existing guidelines for cardiometabolic diseases, and the development of regional and global strategies to combat MASLD are essential to tackle the cardiometabolic pandemic.

I. Gaisin, E. Kochurov, E. А. Loshkarev et al. · 0 citations
Review Open access Nov 2026

Pregnancy and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Introduction . Metabolic dysfunction‑associated steatotic liver disease (MASLD) demonstrates a significant prevalence among women of reproductive age (approximately 10 %), yet the pathophysiological mechanisms of its impact on gestation remain insufficiently understood, and management algorithms for patients before,...

I. Gaisin, Ахметсалим Сабирович Галеев · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.